Novartis India acquires Pfizer brands for $132m

Novartis India has agreed to pay $132m to acquire the Minipres and Minipress trademarks in India, along with certain associated intellectual property rights, from Pfizer and Pfizer Products. The purchase adds an established hypertension brand to the company's cardiovascular range. Novartis India’s board cleared the deal, after which the company signed an asset purchase agreement with Pfizer entities. Credit: JHVEPhoto / Shutterstock.com. Novartis India has agreed to pay Rs12.5bn ($132m) to acquire the Minipres and Minipress trademarks in India, along with certain associated intellectual property rights, from Pfizer and Pfizer Products. The purchase adds an established hypertension brand to Novartis’…

Source: Pharmaceutical Technology